Haemonetics Corporation Cash and Restricted Cash
Haemonetics Corporation (HAE) had Cash and Restricted Cash of $223.38 million as of 2026-06-27, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-27: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $223.38M.
- 2026-03-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $245.44M.
- 2025-12-27: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $363.37M.
- 2025-09-27: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $296.43M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-27 | $223.38M 10-Q · filed 2026-08-06 |
| 2026-03-28 | $245.44M 10-Q · filed 2026-08-06 |
| 2025-12-27 | $363.37M 10-Q · filed 2026-02-05 |
| 2025-09-27 | $296.43M 10-Q · filed 2025-11-06 |
| 2025-06-28 | $292.90M 10-Q · filed 2026-08-06 |
| 2025-03-29 | $306.76M 10-Q · filed 2026-08-06 |
| 2024-12-28 | $320.85M 10-Q · filed 2026-02-05 |
| 2024-09-28 | $299.28M 10-Q · filed 2025-11-06 |
| 2024-06-29 | $344.43M 10-Q · filed 2025-08-07 |
| 2024-03-30 | $178.80M 10-K · filed 2026-05-20 |
| 2023-12-30 | $193.98M 10-Q · filed 2025-02-06 |
| 2023-09-30 | $351.00M 10-Q · filed 2024-11-07 |
| 2023-07-01 | $285.72M 10-Q · filed 2024-08-08 |
| 2023-04-01 | $284.47M 10-K · filed 2026-05-20 |
| 2022-12-31 | $224.00M 10-Q · filed 2024-02-08 |
| 2022-10-01 | $241.20M 10-Q · filed 2023-11-02 |
| 2022-07-02 | $214.95M 10-Q · filed 2023-08-08 |
| 2022-04-02 | $259.50M 10-K · filed 2025-05-21 |
| 2022-01-01 | $236.88M 10-Q · filed 2023-02-07 |
| 2021-10-02 | $192.42M 10-Q · filed 2022-11-08 |
| 2021-07-03 | $173.46M 10-Q · filed 2022-08-10 |
| 2021-04-03 | $192.31M 10-K · filed 2024-05-20 |
| 2020-03-28 | $137.31M 10-K · filed 2023-05-22 |
| 2019-03-30 | $169.35M 10-K · filed 2022-05-25 |
| 2018-03-31 | $180.17M 10-K · filed 2021-05-26 |
| 2017-04-01 | $139.56M 10-K · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |